Curia Italy Srl, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is CHLORTHALIDONE USP-EP, with a corresponding US DMF Number 2438.
Remarkably, this DMF maintains an Active status since its submission on April 21, 1975, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 18, 2013, and payment made on December 20, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II